AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
AAC.00559-07v1
51/9/3445    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Julian, K.
Right arrow Articles by Appelbaum, P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Julian, K.
Right arrow Articles by Appelbaum, P. C.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, September 2007, p. 3445-3448, Vol. 51, No. 9
0066-4804/07/$08.00+0     doi:10.1128/AAC.00559-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Characterization of a Daptomycin-Nonsusceptible Vancomycin-Intermediate Staphylococcus aureus Strain in a Patient with Endocarditis{triangledown}

Kathleen Julian,1* Klaudia Kosowska-Shick,1 Cynthia Whitener,1 Martin Roos,2 Harald Labischinski,2 Aileen Rubio,3 Leslie Parent,1 Lois Ednie,1 Laura Koeth,4 Tatiana Bogdanovich,1 and Peter C. Appelbaum1

Pennsylvania State University Milton S. Hershey Medical Center, Hershey, Pennsylvania,1 Combinature Biopharm AG, Berlin, Germany,2 Cubist Pharmaceuticals, Lexington, Massachusetts,3 Laboratory Specialists, Inc., Westlake, Ohio4

Received 28 April 2007/ Returned for modification 1 June 2007/ Accepted 2 July 2007

We analyzed the emergence of daptomycin nonsusceptibility in a patient with persistent vancomycin-intermediate Staphylococcus aureus (VISA) bacteremia. The daptomycin-nonsusceptible VISA's cell wall demonstrated a reduction in muramic acid O-acetylation, a phenotypic parameter not previously reported for VISA; some isolates also contained a single point mutation in the mprF gene.


* Corresponding author. Mailing address: Penn State Milton S. Hershey Medical Center, Room C6833, BMR Bldg., Mailcode H036, 500 University Dr., Hershey, PA 17033. Phone: (717) 531-8881. Fax: (717) 531-4633. E-mail: kjulian{at}psu.edu

{triangledown} Published ahead of print on 9 July 2007.


Antimicrobial Agents and Chemotherapy, September 2007, p. 3445-3448, Vol. 51, No. 9
0066-4804/07/$08.00+0     doi:10.1128/AAC.00559-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.